Stay updated on Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial
Sign up to get notified when there's something new on the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page.

Latest updates to the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedExpanded the Locations section with updated site listings across US states, Australia, and Canada, and updated the page revision to v3.3.3. Previous location blocks were replaced.SummaryDifference1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedDifference0.1%

- Check31 days agoChange DetectedRevision tag updated from v3.3.1 to v3.3.2 in the page footer; no changes to study information or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed and includes Last Update Posted (Estimated) and Revision: v3.3.1. The older PubMed description and Last Update/Revision notes (v3.2.0) have been removed.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded Hôpital Cochin to the list of study sites and updated the Last Update Posted timestamp, and removed the HOP Cochin entry and the government funding notice.SummaryDifference0.3%

- Check60 days agoChange DetectedAdministrative updates were added on 2025-10-27 and 2025-10-29, with deletions on 2025-10-13 and 2025-10-20. There are no changes to the study design, eligibility criteria, primary outcomes, or reported results.SummaryDifference0.3%

Stay in the know with updates to Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing Brigimadlin With Doxorubicin in Liposarcoma Clinical Trial page.